Oberg Kjell, Astrup Lone, Eriksson Barbro, Falkmer Sture E, Falkmer Ursula G, Gustafsen Jens, Haglund Caj, Knigge Ulrich, Vatn Morten H, Välimäki Matti
Department of Endocrine Oncology, University Hospital, Uppsala, Sweden.
Acta Oncol. 2004;43(7):626-36. doi: 10.1080/02841860410018584.
Part II of the guidelines contains a description of epidemiology, histopathology, clinical presentation, diagnostic procedure, treatment, and survival for each type of neuroendocrine tumour. We are not only including gastroenteropancreatic tumours but also bronchopulmonary and thymic neuroendocrine tumours. These guidelines essentially cover basic knowledge in the diagnosis and management of the different forms of neuroendocrine tumour. We have, however, tried to give more updated information about the epidemiology and histopathology, which is essential for the clinical management of these tumours.
本指南的第二部分包含了每种类型神经内分泌肿瘤的流行病学、组织病理学、临床表现、诊断程序、治疗方法及生存率的描述。我们不仅纳入了胃肠胰腺肿瘤，还包括支气管肺和胸腺神经内分泌肿瘤。这些指南基本涵盖了不同形式神经内分泌肿瘤诊断和管理的基础知识。然而，我们已尽力提供有关流行病学和组织病理学的更新信息，这对这些肿瘤的临床管理至关重要。
